I et klinisk studie, AVF2192g blev der inkluderet patienter med metastatisk kolorektalkræft, som ikke var kandidater til behandling med irinotecan.
In one clinical trial, AVF2192g, patients with metastatic colorectal cancer who were not candidates for treatment with irinotecan were included.